1. Home
  2. ULBI vs CMPX Comparison

ULBI vs CMPX Comparison

Compare ULBI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • CMPX
  • Stock Information
  • Founded
  • ULBI 1990
  • CMPX 2014
  • Country
  • ULBI United States
  • CMPX United States
  • Employees
  • ULBI N/A
  • CMPX N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULBI Miscellaneous
  • CMPX Health Care
  • Exchange
  • ULBI Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • ULBI 158.1M
  • CMPX 214.6M
  • IPO Year
  • ULBI 1992
  • CMPX N/A
  • Fundamental
  • Price
  • ULBI $7.76
  • CMPX $2.00
  • Analyst Decision
  • ULBI Strong Buy
  • CMPX Strong Buy
  • Analyst Count
  • ULBI 1
  • CMPX 4
  • Target Price
  • ULBI $14.00
  • CMPX $13.75
  • AVG Volume (30 Days)
  • ULBI 54.3K
  • CMPX 1.8M
  • Earning Date
  • ULBI 02-13-2025
  • CMPX 11-12-2024
  • Dividend Yield
  • ULBI N/A
  • CMPX N/A
  • EPS Growth
  • ULBI 115.20
  • CMPX N/A
  • EPS
  • ULBI 0.54
  • CMPX N/A
  • Revenue
  • ULBI $165,152,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • ULBI $3.26
  • CMPX N/A
  • Revenue Next Year
  • ULBI $36.05
  • CMPX $613.39
  • P/E Ratio
  • ULBI $14.23
  • CMPX N/A
  • Revenue Growth
  • ULBI 9.95
  • CMPX N/A
  • 52 Week Low
  • ULBI $6.63
  • CMPX $0.77
  • 52 Week High
  • ULBI $13.39
  • CMPX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 55.36
  • CMPX 65.48
  • Support Level
  • ULBI $7.15
  • CMPX $1.43
  • Resistance Level
  • ULBI $7.83
  • CMPX $2.68
  • Average True Range (ATR)
  • ULBI 0.28
  • CMPX 0.24
  • MACD
  • ULBI 0.05
  • CMPX 0.06
  • Stochastic Oscillator
  • ULBI 86.05
  • CMPX 46.87

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

Share on Social Networks: